Recurrent Breast Cancer Withdrawn Phase Trials for Irinotecan (DB00762)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01939483A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS MetastasesTreatment